Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Biofrontera (BFRIW) Accumulated Depreciation & Amortization (2020 - 2025)

Biofrontera has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $267000.0 for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $267000.0 for Q4 2025, down 56.44% from a year ago — trailing twelve months through Dec 2025 was $267000.0 (down 56.44% YoY), and the annual figure for FY2025 was $267000.0, down 56.44%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $267000.0 at Biofrontera, down from $613000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for BFRIW hit a ceiling of $613000.0 in Q4 2024 and a floor of $267000.0 in Q4 2025.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $472500.0 (2022), compared with a mean of $463400.0.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 39.52% in 2021 and later tumbled 56.44% in 2025.
  • Biofrontera's Accumulated Depreciation & Amortization stood at $406000.0 in 2021, then grew by 24.88% to $507000.0 in 2022, then increased by 9.86% to $557000.0 in 2023, then rose by 10.05% to $613000.0 in 2024, then tumbled by 56.44% to $267000.0 in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $267000.0 (Q4 2025), $613000.0 (Q4 2024), and $557000.0 (Q4 2023) per Business Quant data.